Anthony M Joshua

42PUBLICATIONS
390CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersPharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Aug 27, 2026
Advancing Homologous Recombination Repair Mutation Testing in Prostate Cancer in Australia: Shifting the Focus to Hormone Sensitive Prostate Cancer.

|Aug 13, 2026
Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

|Jul 22, 2026
Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance.

|Jun 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Apr 28, 2026
177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Apr 15, 2026
Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial.

Pageof 7

Frequent Collaborators

7 joint publications

Ian D Davis

7 joint publications

Martin R Stockler

4 joint publications

Louise Emmett

4 joint publications

Hui-Ming Lin